Picture this: the leader of the free world, who just so happens to be a fast-food aficionado, confesses he might need a little help in the weight department. Yes, President Donald Trump, the self-proclaimed healthiest president in history, has admitted that he could probably use a GLP-1 weight-loss medication like Ozempic or Wegovy. Now, isn’t that a twist worthy of a political thriller?
Despite his notorious love for McDonald’s hamburgers and fries, Trump has always boasted of his supreme physical health. In 2023, the president clocked in at a hefty 240 pounds, which, according to the body mass index, placed him in the clinically “obese” category. But like a true showman, he lost 16 pounds by his 2025 physical. At 79, he managed to bring himself down to 224 pounds. And how did he achieve this miraculous transformation? Surely not through a balanced diet or regular exercise. No, no, those are for the common folk. For Trump, it’s all in the genes. His parents, he claims, blessed him with “very good genetics.” Apparently, good genes are like a permanent gym membership.
When asked if he’s tried the so-called “fat drugs,” Trump candidly responded that he had not, but “probably should.” For a man who finds exercise “boring,” it’s a revelation of epic proportions. While the rest of us mere mortals slog on treadmills, Trump’s workout of choice is golf. “To walk on a treadmill or run on a treadmill for hours and hours like some people do, that’s not for me,” he quipped. Well, at least he’s consistent.
And speaking of consistency, Trump’s dietary habits are as predictable as a sunrise. Fast food is his kryptonite, with Diet Coke being his drink of choice. Vegetables? Those are for rabbits. Why eat a salad when you can have a Big Mac? His culinary choices are as subtle as a sledgehammer, and his disdain for whole foods is legendary.
But the plot thickens. Despite his skepticism about GLP-1 drugs, Trump is not above a little double-dealing. He’s mocked his “fat” friends for their reliance on these medications, questioning their effectiveness. “You don’t look it to me,” he’d tell them, with his characteristic subtlety. Yet, in a stunning plot twist, he’s been working to slash the costs of these very drugs. Cue the applause.
In a move that could rival any political chess game, Trump announced a deal with pharmaceutical giants Eli Lilly and Novo Nordisk to offer GLP-1 drugs at reduced prices. He even launched TrumpRx.gov, a website promising hefty discounts on pricey medicines, including the GLP-1s he so affectionately calls “the fat drug.” It’s a masterclass in playing both sides of the board.
So here we are, in 2026, watching this saga unfold like a gripping drama. Trump’s confession about needing GLP-1s is just another chapter in his larger-than-life narrative. Whether it’s a strategic move to endear himself to the public or a genuine moment of self-awareness, one thing is certain: the world will be watching his next move with bated breath. And as the curtain falls on this act, one can’t help but wonder: what’s the real endgame here?